Steno Diabetes Center Copenhagen
Quick facts
Marketed products
- insulin aspart + insulin aspart protamin · Diabetes
This is a biphasic insulin formulation combining rapid-acting insulin aspart with intermediate-acting insulin aspart protamine to provide both immediate and sustained blood glucose control. - LOKELMA 5 GM Powder for Oral Suspension · Nephrology / Cardiology
Lokelma (sodium zirconium cyclosilicate) is a potassium binder that traps potassium in the gastrointestinal tract and increases fecal potassium excretion. - Low-Dose Glucagon · Diabetes
Low-dose glucagon activates glucagon receptors to stimulate hepatic glucose output and counteract hypoglycemia in diabetes patients. - Placebo-Metformin · Diabetes
Metformin reduces hepatic glucose production and improves insulin sensitivity, thereby lowering blood glucose levels in type 2 diabetes. - Placebo-Repaglinide · Diabetes
Repaglinide is a meglitinide that stimulates insulin secretion from pancreatic beta cells by closing ATP-sensitive potassium channels. - Spironolacton (hexalacton(R)) · Cardiovascular
Spironolactone is a potassium-sparing diuretic and aldosterone antagonist that blocks aldosterone receptors in the collecting duct of the kidney to reduce sodium reabsorption and increase potassium retention.
Phase 3 pipeline
- Irbesartan treatment · Cardiovascular
Irbesartan blocks angiotensin II type 1 receptors, reducing vasoconstriction and aldosterone secretion to lower blood pressure.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Steno Diabetes Center Copenhagen portfolio CI brief
- Steno Diabetes Center Copenhagen pipeline updates RSS
Frequently asked questions about Steno Diabetes Center Copenhagen
What are Steno Diabetes Center Copenhagen's marketed drugs?
Top marketed products include insulin aspart + insulin aspart protamin, LOKELMA 5 GM Powder for Oral Suspension, Low-Dose Glucagon, Placebo-Metformin, Placebo-Repaglinide, Spironolacton (hexalacton(R)).
What is Steno Diabetes Center Copenhagen's pipeline?
Steno Diabetes Center Copenhagen has 1 drugs in Phase 3, 0 in Phase 2, 2 in Phase 1. Late-stage candidates include Irbesartan treatment.
Related
- insulin aspart + insulin aspart protamin · Diabetes
- LOKELMA 5 GM Powder for Oral Suspension · Nephrology / Cardiology
- Low-Dose Glucagon · Diabetes
- Placebo-Metformin · Diabetes
- Placebo-Repaglinide · Diabetes
- Sector hub: All tracked pharma companies